Short-term Peripheral Venous Catheter-Related Bloodstream Infections: A Systematic Review

Clinical Infectious Diseases

Volumn 65, Issue 10, 2017, Pages 1757-1762

  Mermel, Leonard A ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

bacteremia; bloodstream infection; catheter; catheter infection; peripheral venous catheter

Indexed keywords

BACTERIAL COLONIZATION; CATHETER INFECTION; HUMAN; INFECTION RISK; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; BACTEREMIA; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; STAPHYLOCOCCUS INFECTION;

BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85032719247     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix562     Document Type: Review

References (66)

1. Hadaway L. Short peripheral intravenous catheters and infections. J Infus Nurs 2012; 35:230-40.
2. Réseau d'Alerte, d'Investigation et de Surveillance des Infections Nosocomiales (RAISIN). Enquête nationale de prévalence 2012 des infections nosocomiales et des traitements anti-infectieux en établissements de santé-Mai-juin 2012. Protocole/Guide de l'enquêteur. Saint-Maurice: Institut de veille sanitaire, 2012.
3. Reilly J, Stewart S, Allardice GA, et al. Results from the Scottish National HAI prevalence survey. J Hosp Infect 2008; 69:62-8.
4. Guembe M, Perez-Granda MJ, Capdevila JA, et al. Nationwide study on the use of intravascular catheters in internal medicine departments. J Hosp Infect 2015; 90:135-41.
5. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258:2396-403.
6. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. a randomized controlled trial. Ann Intern Med 1991; 114:845-54.
7. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med 1973; 79:867-87.
8. Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents 2009; 34(suppl 4):S38-42.
9. Lee WL, Chen HL, Tsai TY, et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control 2009; 37:683-6.
10. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998; 158:151-6.
11. Zhang L, Morrison M, Nimmo GR, et al. Molecular investigation of bacterial communities on the inner and outer surfaces of peripheral venous catheters. Eur J Clin Microbiol Infect Dis 2013; 32:1083-90.
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 2009; 3:e123-30.
13. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81:1159-71.
14. Noble CJ, Morgan-Capner P, Hammer M, Sivyer C, Wagstaff P, Pattison JR. A trial of povidone iodine dry powder spray for the prevention of infusion thrombophlebitis. J Hosp Infect 1980; 1:47-51.
15. Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and Teflon catheters. a comparative study. Am J Med 1981; 70:702-6.
16. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983; 118:839-51.
17. Nyström B, Larsen SO, Dankert J, et al. Bacteraemia in surgical patients with intravenous devices: a European multicentre incidence study. The European Working Party on Control of Hospital Infections. J Hosp Infect 1983; 4:338-49.
18. Cheesbrough JS, Finch RG, MacFarlane JT. The complications of intravenous cannulae incorporating a valved injection side port. J Hyg (Lond) 1984; 93:497-504.
19. Larson E, Hargiss C. A decentralized approach to maintenance of intravenous therapy. Am J Infect Control 1984; 12:177-86.
20. Gantz NM, Presswood GM, Goldberg R, Doern G. Effects of dressing type and change interval on intravenous therapy complication rates. Diagn Microbiol Infect Dis 1984; 2:325-32.
21. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. a prospective controlled study. Arch Intern Med 1984; 144:1191-4.
22. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA 1987; 258:1777-81.
23. Hoffmann KK, Western SA, Kaiser DL, Wenzel RP, Groschel DH. Bacterial colonization and phlebitis-associated risk with transparent polyurethane film for peripheral intravenous site dressings. Am J Infect Control 1988; 16:101-6.
24. Jacquot C, Fauvage B, Bru JP, Croize J, Calop J. Cathétérisme veineux périphérique: influence de la composition du cathéter dans l'apparition de thrombophlébites. Ann Fr Anesth Reanim 1989; 8:620-4.
25. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28:2520-5.
26. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158:473-7.
27. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002; 23:249-53.
28. Bouza E, Muñoz P, López-Rodríguez J, et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect 2003; 54:279-87.
29. Barbut F, Pistone T, Guiguet M, et al. Complications liées au cathétérisme veineux périphérique: etude prospective. Presse Med, 2003; 32:450-6.
30. Aygun G, Yasar H, Yilmaz M, et al. The value of Gram staining of catheter segments for rapid detection of peripheral venous catheter infections. Diagn Microbiol Infect Dis 2006; 54:165-7.
31. Lolom I, Deblangy C, Capelle A, et al. Impact d'un programme prolongé d'amélioration continue de la qualité sur le risque infectieux lié aux cathéters veineux périphériques. Presse Med 2009; 38:34-42.
32. Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med 2010; 8:53.
33. Marsh N, Webster J, Flynn J, et al. Securement methods for peripheral venous catheters to prevent failure: a randomised controlled pilot trial. J Vasc Access 2015; 16:237-44.
34. Collignon PJ, Munro R, Sorrell TC. Systemic sepsis and intravenous devices. A prospective survey. Med J Aust 1984; 141:345-8.
35. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161:374-8.
36. Collignon PJ, Dreimanis DE, Beckingham WD, Roberts JL, Gardner A. Intravascular catheter bloodstream infections: an effective and sustained hospital-wide prevention program over 8 years. Med J Aust 2007; 187:551-4.
37. Almirante B, Limón E, Freixas N, Gudiol F; VINCat Program. Laboratory-based surveillance of hospital-acquired catheter-related bloodstream infections in Catalonia. Results of the VINCat Program (2007-2010). Enferm Infecc Microbiol Clin, 2012; 30(suppl 3): 13-9.
38. Delgado-Capel M, Gabillo A, Elías L, Yébenes JC, Sauca G, Capdevila JA. Características de la bacteriemia relacionada con catéter venoso periférico en un hospital general. Rev Esp Quimioter 2012; 25:129-133.
39. Freixas N, Bella F, Limón E, Pujol M, Almirante B, Gudiol F. Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study. Clin Microbiol Infect 2013; 19:838-44.
40. Fry DE, Borzotta AP. Nosocomial blood-borne infection secondary to intravascular devices. Am J Surg 1994; 167:268-72.
41. Coello R, Charlett A, Ward V, et al. Device-related sources of bacteraemia in English hospitals-opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect 2003; 53:46-57.
42. Pujol M, Hornero A, Saballs M, et al. Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital. J Hosp Infect 2007; 67:22-9.
43. Fakih MG, Jones K, Rey JE, et al. Sustained improvements in peripheral venous catheter care in non-intensive care units: a quasi-experimental controlled study of education and feedback. Infect Control Hosp Epidemiol 2012; 33:449-55.
44. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals. Stockholm, Sweden: ECDC; 2013.
45. Fakih MG, Jones K, Rey JE, et al. Peripheral venous catheter care in the emergency department: education and feedback lead to marked improvements. Am J Infect Control 2013; 41:531-6.
46. Mestre G, Berbel C, Tortajada P, et al. Successful multifaceted intervention aimed to reduce short peripheral venous catheter-related adverse events: a quasiexperimental cohort study. Am J Infect Control 2013; 41:520-6.
47. Collignon PJ, Kimber FJ, Beckingham WD, Roberts JL. Prevention of peripheral intravenous catheter-related bloodstream infections: the need for routine replacement. Med J Aust 2013; 199:750-1.
48. Safdar N, McKinley LM, Davidson B, Broome C, Schenk J. Recommendations to replace peripheral venous catheters every 72-96 hours: is a single reference enough? J Hosp Infect 2011; 79:172-3.
49. Austin ED, Sullivan SB, Whittier S, Lowy FD, Uhlemann AC. Peripheral intravenous catheter placement is an underrecognized source of Staphylococcus aureus bloodstream infection. Open Forum Infect Dis 2016; 3:ofw072.
50. Mylotte JM, McDermott C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control 1987; 15:1-6.
51. Thomas MG, Morris AJ. Cannula-associated Staphylococcus aureus bacteraemia: outcome in relation to treatment. Intern Med J 2005; 35:319-30.
52. Kok J, O'Sullivan MV, Gilbert GL. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates. J Hosp Infect 2011; 79:108-14.
53. Trinh TT, Chan PA, Edwards O, et al. Peripheral venous catheter-related Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2011; 32:579-83.
54. Morris AK, Russell CD. Enhanced surveillance of Staphylococcus aureus bacteraemia to identify targets for infection prevention. J Hosp Infect 2016; 93:169-74.
55. Bruno M, Brennan D, Redpath MB, et al. Peripheral-venous-catheter-related Staphylococcus aureus bacteraemia: a multi-factorial approach to reducing incidence. J Hosp Infect 2011; 79:173-4.
56. Stuart RL, Cameron DR, Scott C, et al. Peripheral intravenous catheter-associated Staphylococcus aureus bacteraemia: more than 5 years of prospective data from two tertiary health services. Med J Aust 2013; 198:551-3.
57. Rhodes D, Cheng AC, McLellan S, et al. Reducing Staphylococcus aureus bloodstream infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Infect 2016; 94:86-91.
58. Sabri A, Szalas J, Holmes KS, Labib L, Mussivand T. Failed attempts and improvement strategies in peripheral intravenous catheterization. Biomed Mater Eng 2013; 23:93-108.
59. Alexandrou E, Ray-Barruel G, Carr PJ, et al. International prevalence of the use of peripheral intravenous catheters. J Hosp Med 2015; 10:530-3.
60. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-93.
61. Prévention des infections liées aux cathéters veineux périphériques. Recommandations pour la pratique clinique. La Société française d'hygiène hospitalière. 2005.
62. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
63. Erratum in: Clin Infect Dis 2010; 50(7):1079.
64. Clin Infect Dis 2010; 50(3): 457.
65. Capdevila JA, Guembe M, Barberán J, et al. 2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adult. Rev Esp Quimioter 2016; 29:230-8.
66. Loveday HP, Wilson JA, Pratt RJ, et al. Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2014; 86(suppl 1):S1-70.